The anti-fibrotic effects of microRNA-153 by targeting TGFBR-2 in pulmonary fibrosis

Experimental and Molecular Pathology

Volumn 99, Issue 2, 2015, Pages 279-285

  Liang, Chunlian ^a   Li, Xiuli ^a   Zhang, Lin ^a   Cui, Dajiang ^a   Quan, Xiaojuan ^a   Yang, Weilin ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Idiopathic pulmonary fibrosis; miR 153; TGF ; TGFBR2

Indexed keywords

MICRORNA; MICRORNA 153; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; UNCLASSIFIED DRUG; ANTINEOPLASTIC ANTIBIOTIC; BLEOMYCIN; MESSENGER RNA; MIRN153 MICRORNA, MOUSE; PROTEIN SERINE THREONINE KINASE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR-BETA TYPE II RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL ACTIVITY; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; FIBROBLAST; FIBROSING ALVEOLITIS; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; WOUND HEALING; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CELL CULTURE; CELL MOTION; CHEMICALLY INDUCED; CYTOLOGY; DRUG EFFECTS; GENETICS; LUNG; METABOLISM; PULMONARY FIBROSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

MUS;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BLEOMYCIN; BLOTTING, WESTERN; CELL MOVEMENT; CELLS, CULTURED; FIBROBLASTS; HUMANS; LUNG; MICE; MICE, INBRED C57BL; MICRORNAS; PROTEIN-SERINE-THREONINE KINASES; PULMONARY FIBROSIS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA1; WOUND HEALING;

EID: 84938369840     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2015.07.011     Document Type: Article

References (31)

1. Berschneider B., Ellwanger D.C., Baarsma H.A., et al. miR-92a regulates TGF-β1-induced WISP1 expression in pulmonary fibrosis. Int. J. Biochem. Cell Biol. 2014, 53:432-441.
2. Chaudhary N.I., Schnapp A., Park J.E. Pharmacologic differentiation of inflammation and fibrosis in the rat bleomycin model. Am. J. Respir. Crit. Care Med. 2006, 173(7):769-776.
3. Cushing L., Kuang P.P., Qian J., et al. MIR-29 is a major regulator of genes associated with pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 2011, 45(2):287-294.
4. Das S., Kumar M., Negi V., et al. MicroRNA-326 regulates pro-fibrotic functions of transforming growth factor-βin pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 2014, 50(5):882-892.
5. Finlay G.A., Thannickal V.J., Fanburg B.L., et al. Transforming growth factor-beta 1 induced activation of the ERK pathway/activator protein-1 in human lung fibroblasts requires the autocrine induction of basic fibroblast growth factor. J. Biol. Chem. 2000, 275(36):27650-27656.
6. Harazono Y., Muramatsu T., Endo H., et al. miR-655 is an EMT-suppressive microRNA targeting ZEB1 and TGFBR2. PLoS One 2013, 8(5):e62757.
7. Hardie W.D., Glasser S.W., Hagood J.S. Emerging concepts in the pathogenesis of lung fibrosis. Am. J. Pathol. 2009, 175(1):3-16.
8. Keklikoglou I., Koerner C., Schmidt C., et al. MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-kB and TGF-b signaling pathways. Oncogene 2012, 31(37):4150-4163.
9. Khalil N., Parekh T.V., O'Connor R., et al. Regulation of the effects of TGF-beta 1 by activation of latent TGF-beta 1 and differential expression of TGF-beta receptors (T beta R-I and T beta R-II) in idiopathic pulmonary fibrosis. Thorax 2001, 56(12):907-915.
10. Lee R.C., Ambros V. An extensive class of small RNAs in Caenorhabditis elegans. Science 2001, 294(5543):862-864.
11. Levy C., Khaled M., Iliopoulos D., et al. Intronic miR-211 assumes the tumor suppressive function of its host gene in melanoma. Mol. Cell 2010, 40(5):841-849.
12. Liang C., Zhu H., Xu Y., et al. MicroRNA-153 negatively regulates the expression of amyloid precursor protein and amyloid precursor-like protein 2. Brain Res. 2012, 1455:103-113.
13. Liang H., Gu Y., Li T., et al. Integrated analyses identify the involvement of microRNA-26a in epithelial-mesenchymal transition during idiopathic pulmonary fibrosis. Cell Death Dis. 2014, 5:e1238.
14. Liang H., Xu C., Pan Z., et al. The anti-fibrotic effects and mechanisms of microRNA-26a in idiopathic pulmonary fibrosis. Mol. Ther. 2014, 22(6):1122-1133.
15. Liu G., Friggeri A., Yang Y., et al. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J. Exp. Med. 2010, 207(8):1589-1597.
16. Massague J. TGFbeta signaling: receptors, transducers, and Mad proteins. Cell 1996, 85(7):947-950.
17. Nana-Sinkam S.P., Hunter M.G., Nuovo G.J., et al. Integrating the MicroRNome into the study of lung disease. Am. J. Respir. Crit. Care Med. 2009, 179(1):4-10.
18. Niu G., Li B., Sun L., et al. MicroRNA-153 inhibits osteosarcoma cells proliferation and invasion by targeting TGF-β2. PLoS One 2015, 10(3):e0119225.
19. Pandit K.V., Corcoran D., Yousef H., et al. Inhibition and role of let-7d in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2010, 182(2):220-229.
20. Schultz N., Marenstein D.R., De Angelis D.A., et al. Off-target effects dominate a large-scale RNAi screen for modulators of the TGF-b pathway and reveal microRNA regulation of TGFBR2. Silence 2011, 2:3.
21. Verma S., Slutsky A.S. Idiopathic pulmonary fibrosis-new insights. N. Engl. J. Med. 2007, 356(13):1370-1372.
22. Wipff P.J., Rifkin D.B., Meister J.J., et al. Myofibroblast contraction activates latent TGF-β1 from the extracellular matrix. J. Cell Biol. 2007, 179(6):1311-1323.
23. Wynn T.A. Integrating mechanisms of pulmonary fibrosis. J. Exp. Med. 2011, 208(7):1339-1350.
24. Xiao J., Meng X.M., Huang X.R., et al. miR-29 inhibits bleomycin-induced pulmonary fibrosis in mice. Mol. Ther. 2012, 20(6):1251-1260.
25. Xie T., Liang J., Guo R., et al. Comprehensive microRNA analysis in bleomycin-induced pulmonary fibrosis identifies multiple sites of molecular regulation. Physiol. Genomics 2011, 43(9):479-487.
26. Xu J., Liao X., Wong C. Downregulations of B-cell lymphoma 2 and myeloid cell leukemia sequence 1 by microRNA 153 induce apoptosis in a glioblastoma cell line DBTRG-05MG. Int. J. Cancer 2010, 126(4):1029-1035.
27. Xu Q., Sun Q., Zhang J., et al. Downregulation of miR-153 contributes to epithelial-mesenchymal transition and tumor metastasis in human epithelial cancer. Carcinogenesis 2013, 34(3):539-549.
28. Yang S., Cui H., Xie N., et al. miR-145 regulates myofibroblast differentiation and lung fibrosis. FASEB J. 2013, 27(6):2382-2391.
29. Yang S., Xie N., Cui H., et al. miR-31 is a negative regulator of fibrogenesis and pulmonary fibrosis. FASEB J. 2012, 26(9):3790-3799.
30. Yi E.S., Lee H., Yin S., et al. Platelet-derived growth factor causes pulmonary cell proliferation and collagen deposition in vivo. Am. J. Pathol. 1996, 149(2):539-548.
31. Zhao Y. Transforming growth factor-beta (TGF-beta) type I and type II receptors are both required for TGF-beta-mediated extracellular matrix production in lung fibroblasts. Mol. Cell. Endocrinol. 1999, 150(1-2):91-97.